BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15517140)

  • 41. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
    Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
    Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cine CT for attenuation correction in cardiac PET/CT.
    Alessio AM; Kohlmyer S; Branch K; Chen G; Caldwell J; Kinahan P
    J Nucl Med; 2007 May; 48(5):794-801. PubMed ID: 17475969
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [CT/PET image registration based on a region similarity measure].
    Yi CL; Du MH
    Zhongguo Yi Liao Qi Xie Za Zhi; 2005 Jan; 29(1):7-10, 12. PubMed ID: 15875683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
    Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
    Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acquisition protocol considerations for combined PET/CT imaging.
    Beyer T; Antoch G; Müller S; Egelhof T; Freudenberg LS; Debatin J; Bockisch A
    J Nucl Med; 2004 Jan; 45 Suppl 1():25S-35S. PubMed ID: 14736833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of different techniques for stereotactic positron emission tomography imaging.
    Novotny J; Nechvil K; Ptacek J; Novotny J; Liscak R
    Stereotact Funct Neurosurg; 2008; 86(1):30-6. PubMed ID: 17881886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Respiratory motion in positron emission tomography/computed tomography: a review.
    Nehmeh SA; Erdi YE
    Semin Nucl Med; 2008 May; 38(3):167-76. PubMed ID: 18396177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retrospective digital image fusion of multidetector CT and 18F-FDG PET: clinical value in pancreatic lesions--a prospective study with 104 patients.
    Lemke AJ; Niehues SM; Hosten N; Amthauer H; Boehmig M; Stroszczynski C; Rohlfing T; Rosewicz S; Felix R
    J Nucl Med; 2004 Aug; 45(8):1279-86. PubMed ID: 15299049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
    Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
    Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PET/MRI: challenges, solutions and perspectives.
    Herzog H
    Z Med Phys; 2012 Dec; 22(4):281-98. PubMed ID: 22925652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements.
    Cohade C; Wahl RL
    Semin Nucl Med; 2003 Jul; 33(3):228-37. PubMed ID: 12931324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
    Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
    J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
    Jadvar H; Henderson RW; Conti PS
    J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Computed tomography-based attenuation correction in neurological positron emission tomography: evaluation of the effect of the X-ray tube voltage on quantitative analysis.
    Reza Ay M; Zaidi H
    Nucl Med Commun; 2006 Apr; 27(4):339-46. PubMed ID: 16531919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
    Chavdarova LI; Tzonevska AD; Piperkova EN
    Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT.
    Beyer T; Antoch G; Bockisch A; Stattaus J
    J Nucl Med; 2005 Mar; 46(3):429-35. PubMed ID: 15750155
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.
    Grueneisen J; Nagarajah J; Buchbender C; Hoffmann O; Schaarschmidt BM; Poeppel T; Forsting M; Quick HH; Umutlu L; Kinner S
    Invest Radiol; 2015 Aug; 50(8):505-13. PubMed ID: 26115367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of scatter limitation correction: a new method of correcting photopenic artifacts caused by patient motion during whole-body PET/CT imaging.
    Miwa K; Umeda T; Murata T; Wagatsuma K; Miyaji N; Terauchi T; Koizumi M; Sasaki M
    Nucl Med Commun; 2016 Feb; 37(2):147-54. PubMed ID: 26440565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.